Prana Biotechnology Ltd Sponsored ADR
(NASDAQ : PRAN)

( )
PRAN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading PRAN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.16%70.550.9%$746.71m
AMGNAmgen Inc.
0.00%170.851.1%$707.06m
CELGCelgene Corporation
0.00%130.931.1%$645.79m
REGNRegeneron Pharmaceuticals, Inc.
0.00%502.122.7%$590.62m
BIIBBiogen Inc.
0.00%271.251.2%$491.73m
ALXNAlexion Pharmaceuticals, Inc.
-1.24%120.601.9%$445.24m
VRTXVertex Pharmaceuticals Incorporated
0.00%129.231.9%$271.19m
INCYIncyte Corporation
0.00%130.312.6%$256.98m
CLVSClovis Oncology, Inc.
0.00%89.9618.0%$244.46m
TSROTESARO, Inc.
0.00%141.0314.7%$243.48m
BLUEBluebird Bio, Inc.
0.37%107.3019.3%$160.58m
ILMNIllumina, Inc.
0.00%176.363.5%$150.43m
KITEKite Pharma, Inc.
0.00%98.0516.1%$139.68m
EXASExact Sciences Corporation
0.00%34.0926.3%$128.59m
AAgilent Technologies, Inc.
0.00%58.871.5%$122.37m

Company Profile

Prana Biotechnology Ltd. engages in the development of therapies to treat neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.,05JYC8-E